Siao‐Yi Wang

Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab

J. A. Bowles, Siao‐Yi Wang, Brian K. Link et al. · Blood · 2006 · 223 citations · Full text

Immunology, Nk Cells, Immunologic Mechanism +16

NK-cell activation and antibody-dependent cellular cytotoxicity induced by rituximab-coated target cells is inhibited by the C3b component of complement

Siao‐Yi Wang, Emilian Racila, Ronald P. Taylor et al. · Blood · 2007 · 185 citations · Full text

Depletion of the C3 component of complement enhances the ability of rituximab-coated target cells to activate human NK cells and improves the efficacy of monoclonal antibody therapy in an in vivo model

Siao‐Yi Wang, Suresh Veeramani, Emilian Racila et al. · Blood · 2009 · 133 citations · Full text

Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphism

Suresh Veeramani, Siao‐Yi Wang, Christopher E. Dahle et al. · Blood · 2011 · 119 citations · Full text

miR-19, miR-345, miR-519c-5p Serum Levels Predict Adverse Pathology in Prostate Cancer Patients Eligible for Active Surveillance

Siao‐Yi Wang, Stephen Shiboski, Cassandra D. Belair et al. · PLoS ONE · 2014 · 52 citations · Full text

Prognosis, Pathology, Capra Risk Model +16